• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描(PET)成像显示,酒精依赖者的 κ 阿片受体可用性较低,但与年龄无关。

PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age.

机构信息

Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.

Department of Psychiatry, Yale University, New Haven, CT, USA.

出版信息

Neuropsychopharmacology. 2018 Dec;43(13):2539-2547. doi: 10.1038/s41386-018-0199-1. Epub 2018 Sep 6.

DOI:10.1038/s41386-018-0199-1
PMID:30188515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6224533/
Abstract

Opioid receptors are implicated in alcoholism, other addictions, withdrawal, and depression, and are considered potential pharmacological targets for treatment. Our goal in the present study was to compare the availability of kappa opioid receptors (KOR) between an alcohol-dependent cohort (AD) and a healthy control cohort (HC). Sixty-four participants-36 AD and 28 HC-underwent PET scans with [C]LY2795050, a selective kappa antagonist tracer. Partial-volume correction was applied to all PET data to correct for atrophy. Volume of distribution (V) of the tracer was estimated regionally as a measure of KOR availability. V values of AD versus HC were compared for 15 defined ROIs. Multivariate analysis showed a main effect of group on V across these 15 ROIs. Post hoc tests showed that AD had significantly lower V and thus a lower KOR availability than HC in amygdala and pallidum (corrected for multiple comparisons). Exploratory analysis of change in V with age was conducted; V was not found to vary significantly with age in any region. Our findings of lower V in AD versus HC in multiple regions are in contrast to findings in the mu and delta opioid receptor systems of higher V in AD versus HC. Although age-related decline in receptors has previously been observed in the mu opioid receptor system, we found that KOR availability does not change with age.

摘要

阿片受体与酒精中毒、其他成瘾、戒断和抑郁有关,被认为是治疗的潜在药理学靶点。本研究的目的是比较酒精依赖患者队列(AD)和健康对照组(HC)之间κ 型阿片受体(KOR)的可利用性。64 名参与者——36 名 AD 和 28 名 HC——接受了 [C]LY2795050 的 PET 扫描,这是一种选择性的 κ 拮抗剂示踪剂。对所有 PET 数据都应用了部分体积校正,以校正萎缩。将示踪剂的分布容积(V)作为 KOR 可利用性的衡量标准进行区域性估计。将 AD 与 HC 的 V 值进行比较,比较了 15 个定义明确的 ROI。多变量分析显示,这些 15 个 ROI 上的 V 存在组间的主要效应。事后检验显示,与 HC 相比,AD 的 V 值显著降低,因此 KOR 可利用性较低,杏仁核和苍白球(经多重比较校正)。对 V 随年龄的变化进行了探索性分析;在任何区域,V 都没有随年龄显著变化。我们发现 AD 中 V 低于 HC 的多个区域与 AD 中 V 高于 HC 的 μ 和 δ 型阿片受体系统的发现相反。尽管以前在 μ 型阿片受体系统中观察到与年龄相关的受体下降,但我们发现 KOR 可利用性不会随年龄而变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/d7a481c8fb5d/41386_2018_199_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/2c0009549293/41386_2018_199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/76446da8a316/41386_2018_199_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/4ee16961123c/41386_2018_199_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/d7a481c8fb5d/41386_2018_199_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/2c0009549293/41386_2018_199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/76446da8a316/41386_2018_199_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/4ee16961123c/41386_2018_199_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8239/6224533/d7a481c8fb5d/41386_2018_199_Fig4_HTML.jpg

相似文献

1
PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age.正电子发射断层扫描(PET)成像显示,酒精依赖者的 κ 阿片受体可用性较低,但与年龄无关。
Neuropsychopharmacology. 2018 Dec;43(13):2539-2547. doi: 10.1038/s41386-018-0199-1. Epub 2018 Sep 6.
2
Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.使用11C-LY2795050(一种用于κ阿片受体的拮抗剂PET放射性示踪剂)对人体结合参数进行重测的可重复性。
J Nucl Med. 2015 Feb;56(2):243-8. doi: 10.2967/jnumed.114.147975. Epub 2015 Jan 15.
3
Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.测定新型 κ 阿片受体拮抗剂 PET 示踪剂 11C-LY2795050 在恒河猴体内的选择性。
J Nucl Med. 2013 Sep;54(9):1668-74. doi: 10.2967/jnumed.112.118877. Epub 2013 Aug 5.
4
PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo.正电子发射断层扫描(PET)成像显示,在活体人类中,κ阿片受体的可用性存在性别差异。
Am J Nucl Med Mol Imaging. 2016 Aug 20;6(4):205-14. eCollection 2016.
5
Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050.用正电子发射断层扫描和新型放射性示踪剂11C-LY2795050测量κ-阿片受体拮抗剂LY2456302的受体占有率。
J Pharmacol Exp Ther. 2016 Feb;356(2):260-6. doi: 10.1124/jpet.115.229278. Epub 2015 Dec 1.
6
Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.通过正电子发射断层扫描成像揭示 κ 阿片类激动剂结合的差异。
ACS Chem Neurosci. 2019 Jan 16;10(1):384-395. doi: 10.1021/acschemneuro.8b00293. Epub 2018 Oct 17.
7
Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.评估激动剂PET放射性配体[¹¹C]GR103545用于人体κ阿片受体成像:动力学模型选择、重测可重复性以及拮抗剂PF-04455242对受体的占有率
Neuroimage. 2014 Oct 1;99:69-79. doi: 10.1016/j.neuroimage.2014.05.033. Epub 2014 May 17.
8
Kappa opioid receptor binding in major depression: A pilot study.重度抑郁症中κ阿片受体结合:一项初步研究。
Synapse. 2018 Sep;72(9):e22042. doi: 10.1002/syn.22042. Epub 2018 Jul 17.
9
Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.合成及评估 11C-LY2795050 作为正电子发射断层扫描(PET)成像用 κ-阿片受体拮抗剂放射性示踪剂。
J Nucl Med. 2013 Mar;54(3):455-63. doi: 10.2967/jnumed.112.109512. Epub 2013 Jan 25.
10
Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.测定 11C-GR103545 的体内 Bmax 和 Kd,11C-GR103545 是一种 κ-阿片受体激动剂 PET 示踪剂:在非人灵长类动物中的研究。
J Nucl Med. 2013 Apr;54(4):600-8. doi: 10.2967/jnumed.112.112672. Epub 2013 Feb 19.

引用本文的文献

1
Mapping the microstructure of human cerebral cortex in vivo with diffusion MRI.利用扩散磁共振成像在体绘制人类大脑皮质微观结构图谱。
Commun Biol. 2025 Jul 22;8(1):1088. doi: 10.1038/s42003-025-08523-9.
2
Voluntary Exercise Ameliorates Chronic Ethanol Withdrawal-Induced Adaptations of Opioid Receptor Expression in the Nucleus Accumbens, Dopamine Release, and Ethanol Consumption.自愿运动可改善慢性乙醇戒断诱导的伏隔核中阿片受体表达、多巴胺释放及乙醇消耗的适应性变化。
Biomedicines. 2024 Jul 17;12(7):1593. doi: 10.3390/biomedicines12071593.
3
Kappa-opioid receptor stimulation in the nucleus accumbens shell and ethanol drinking: Differential effects by rostro-caudal location and level of drinking.

本文引用的文献

1
Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis.正常衰老成年人中多巴胺受体和转运体减少但合成能力未降低:一项荟萃分析。
Neurobiol Aging. 2017 Sep;57:36-46. doi: 10.1016/j.neurobiolaging.2017.05.006. Epub 2017 May 12.
2
Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies.药物滥用研究中的性别差异:对23年结构性神经影像学研究的评估
Drug Alcohol Depend. 2017 Apr 1;173:92-98. doi: 10.1016/j.drugalcdep.2016.12.019. Epub 2017 Jan 31.
3
PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo.
伏隔核壳部κ阿片受体刺激与乙醇摄入:与刺激部位的头侧-尾侧位置和摄入水平的差异效应。
Neuropsychopharmacology. 2024 Sep;49(10):1550-1558. doi: 10.1038/s41386-024-01850-1. Epub 2024 Mar 25.
4
Controlling the human connectome with spatially diffuse input signals.利用空间扩散输入信号控制人类连接组
bioRxiv. 2024 Feb 28:2024.02.27.581006. doi: 10.1101/2024.02.27.581006.
5
Opioid modulation of prefrontal cortex cells and circuits.阿片类物质对前额叶皮层细胞和回路的调制。
Neuropharmacology. 2024 May 1;248:109891. doi: 10.1016/j.neuropharm.2024.109891. Epub 2024 Feb 27.
6
Acute Stress Increases Striatal Connectivity With Cortical Regions Enriched for μ and κ Opioid Receptors.急性应激增加富含 μ 和 κ 阿片受体的皮质区域与纹状体的连接。
Biol Psychiatry. 2024 Nov 1;96(9):717-726. doi: 10.1016/j.biopsych.2024.02.005. Epub 2024 Feb 22.
7
Dynamic regulation of CeA gene expression during acute and protracted abstinence from chronic binge drinking of male and female C57BL/6J mice.雄性和雌性C57BL/6J小鼠长期暴饮后急性和延长戒断期间CeA基因表达的动态调节
bioRxiv. 2024 Feb 4:2024.02.02.578650. doi: 10.1101/2024.02.02.578650.
8
Naltrexone engages a brain reward network in the presence of reward-predictive distractor stimuli in males.在存在奖励预测性干扰刺激的情况下,纳曲酮会激活男性大脑中的奖励网络。
Addict Neurosci. 2023 Sep;7. doi: 10.1016/j.addicn.2023.100085. Epub 2023 Apr 2.
9
Insula Dynorphin and Kappa Opioid Receptor Systems Regulate Alcohol Drinking in a Sex-Specific Manner in Mice.岛叶脑啡肽和κ阿片受体系统以性别特异性方式调节小鼠的饮酒行为。
J Neurosci. 2023 Jul 12;43(28):5158-5171. doi: 10.1523/JNEUROSCI.0406-22.2023. Epub 2023 May 22.
10
Clustering of KOR PET images separates people with AUD into distinct responses to naltrexone.KOR PET 图像聚类将 AUD 患者分为对纳曲酮有不同反应的人群。
Brain Imaging Behav. 2023 Jun;17(3):367-371. doi: 10.1007/s11682-023-00758-6. Epub 2023 Jan 25.
正电子发射断层扫描(PET)成像显示,在活体人类中,κ阿片受体的可用性存在性别差异。
Am J Nucl Med Mol Imaging. 2016 Aug 20;6(4):205-14. eCollection 2016.
4
Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.κ阿片受体功能的性别差异及其对成瘾的潜在影响。
Front Neurosci. 2015 Dec 16;9:466. doi: 10.3389/fnins.2015.00466. eCollection 2015.
5
Receptor Occupancy of the κ-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050.用正电子发射断层扫描和新型放射性示踪剂11C-LY2795050测量κ-阿片受体拮抗剂LY2456302的受体占有率。
J Pharmacol Exp Ther. 2016 Feb;356(2):260-6. doi: 10.1124/jpet.115.229278. Epub 2015 Dec 1.
6
Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment.酒精使用障碍的异质性:理解推进个性化治疗的机制
Alcohol Clin Exp Res. 2015 Apr;39(4):579-84. doi: 10.1111/acer.12669.
7
Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.使用11C-LY2795050(一种用于κ阿片受体的拮抗剂PET放射性示踪剂)对人体结合参数进行重测的可重复性。
J Nucl Med. 2015 Feb;56(2):243-8. doi: 10.2967/jnumed.114.147975. Epub 2015 Jan 15.
8
Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.(11)C-LY2795050的动力学建模,一种用于人体κ阿片受体PET成像的新型拮抗剂放射性示踪剂。
J Cereb Blood Flow Metab. 2014 Nov;34(11):1818-25. doi: 10.1038/jcbfm.2014.150. Epub 2014 Sep 3.
9
Pharmacotherapy of alcohol use disorders: seventy-five years of progress.酒精使用障碍的药物治疗:75年的进展
J Stud Alcohol Drugs Suppl. 2014;75(17):79-88. doi: 10.15288/jsads.2014.s17.79.
10
Evaluation of motion correction methods in human brain PET imaging--a simulation study based on human motion data.人脑 PET 成像中运动校正方法的评估——基于人体运动数据的模拟研究。
Med Phys. 2013 Oct;40(10):102503. doi: 10.1118/1.4819820.